Nutritional and Contractile Regulation of Muscle Growth
Sarcopenia
About this trial
This is an interventional basic science trial for Sarcopenia focused on measuring Sarcopenia, Aging, Metabolism, Muscle, mTOR, Essential Amino Acids, Exercise, Rapamycin
Eligibility Criteria
Inclusion Criteria:
- 18 to 35 years of age for the young groups
- 60 to 85 years of age for the older groups
- In the follicular phase for the young women participants
- Ability to sign consent form, as based on a score of greater than 25 on the 30-item Mini Mental State Examination (MMSE)
- Stable body weight for at least 1 year
Exclusion Criteria:
- Physical dependence or frailty, as determined by impairment in any of the activities of daily living (ADLs), history of more than two falls per year, or significant weight loss in the past year
- Exercise training that consists of more than two weekly sessions of moderate to high intensity aerobic or resistance exercise
- Significant heart, liver, kidney, blood, or respiratory disease
- Peripheral vascular disease
- Diabetes mellitus or other untreated endocrine disease
- Active cancer
- History of cancer for participants who may be randomly assigned to rapamycin)
- Acute infectious disease or history of chronic infections (e.g., tuberculosis, hepatitis, HIV, herpes)
- Treatment with anabolic steroids or corticosteroids within 6 months of study entry
- Alcohol or drug abuse
- Tobacco use (smoking or chewing)
- Malnutrition (e.g., body mass index [BMI] less than 20 kg/m2, hypoalbuminemia, and/or hypotransferrinemia)
- Obesity (BMI greater than 30 kg/m2)
- Lower than normal hemoglobin levels
Sites / Locations
- Department of Nutrition & Metabolism, University of Texas Medical Branch
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Arm 8
Arm 9
Arm 10
Arm 11
Arm 12
Arm 13
Arm 14
Active Comparator
Placebo Comparator
Active Comparator
Placebo Comparator
Active Comparator
Placebo Comparator
Active Comparator
Placebo Comparator
Active Comparator
Active Comparator
Active Comparator
Placebo Comparator
Active Comparator
Active Comparator
Exp 1: AA + Rap
Exp 1: AA
Exp 1: HEx + Rap
Exp 1: HEx
Exp 1: HEx + AA + Rap
Exp 1: HEx + AA
Exp 2: LExFR + Rap
Exp 2 and 3: LExFR
Exp 2: SNP
Exp 2: FR
Exp 2: LEx + SNP
Exp 3: LEx
Exp 3: HEx
Exp 3: HEx + AA
Participants will receive amino acid supplementation and rapamycin.
Participants will receive amino acid supplementation and placebo rapamycin.
Participants will receive rapamycin and placebo amino acid supplementation, and they will undergo high-intensity resistance exercise.
Participants will receive placebo amino acid supplementation and placebo rapamycin, and they will undergo high-intensity resistance exercise.
Participants will receive amino acid supplementation and rapamycin, and they will undergo high-intensity resistance exercise.
Participants will receive amino acid supplementation and placebo rapamycin, and they will undergo high-intensity resistance exercise.
Participants will receive rapamycin and will undergo low-intensity resistance exercise with blood flow restriction.
Participants will receive placebo rapamycin and will undergo low-intensity resistance exercise with blood flow restriction.
Participants will receive sodium nitroprusside in a resting state.
Participants will undergo blood flow restriction in a resting state.
Participants will receive sodium nitroprusside and undergo low-intensity resistance exercise.
Participants will undergo low-intensity resistance exercise.
Participants will undergo high-intensity resistance exercise.
Participants will receive amino acid supplementation and will undergo high-intensity resistance exercise.